Cerebrovascular accidents, subarachnoid hemorrhage, arteriovenous malformations, cerebral small vessel disease, intracranial hemorrhage, cerebral amyloid angiopathy Stroke, bleeding around the brain, congenital abnormalities in blood vessels, damage to the small blood vessels in the brain, a hemorrhage inside the skull, the buildup of proteins in the blood vessels of the brain.
Conditions
Sponsors
Universitair Medisch Centrum Groningen
Eligibility
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, patients must meet the following criteria:Diagnosis of a neurovascular disease, including either an acute event (e.g., stroke, SAH, ICH) or a chronic condition (e.g., CSVD, CAA). A neuropsychological assessment (NPA), conducted at the UMCG within the past 6 months, must reveal either mild cognitive impairments or subjective cognitive complaints, combined with difficulties in coping with these issues, reintegrating into daily life, or maintaining daily functioning. Additionally, the neuropsychological profile should not meet the criteria for multidisciplinary post-clinical rehabilitation.Self-efficacy score of below 31 on the self-efficacy questionnaire (Teeuw et al., 1994).Participants must be able to invite a significant other (e.g., partner, family member, or friend) to attend one of the intervention sessions. The significant other does not need to live with the participant.Sufficient understanding of the Dutch language to follow and comprehend the intervention sessions. Age 18 years or older.
Exclusion criteria
Exclusion criteria: Current severe psychiatric conditions or comorbidity with other neurodegenerative diseases that may interfere with the intervention.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome: Change in self-efficacy scores from baseline to follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes: Changes in QoL, daily participation, emotional well-being (e.g., depression, anxiety), and cognitive complaints over the study period. | — |
Countries
Netherlands
Contacts
Public ContactS Khosdelazad
Universitair Medisch Centrum Groningen
Outcome results
None listed